Boehringer Ingelheim is looking for a professional to lead the launch and commercialization of Survodutide, transforming the future of obesity and metabolic health. This opportunity entails shaping brand strategy for a pre-launch asset, with responsibilities including developing customer plans, defining value propositions, and ensuring regulatory compliance.
The ideal candidate should possess over five years in pharmaceutical brand management and a strong record of success in pre-launch or launch settings. Join us to make a significant impact on patient outcomes and lead a high-performing brand team.
Metabolic Health Brand Lead - Launch & Growth in Sydney employer: Boehringer Ingelheim
Boehringer Ingelheim is an excellent employer, offering a collaborative work culture that prioritises patient safety and professional growth. With a focus on employee development and a commitment to high-quality pharmacovigilance processes, you will have the opportunity to make a meaningful impact in healthcare while working in a supportive environment across Australia and New Zealand.
